Home

Market Capitalization of Alembic Pharmaceuticals Ltd

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Market Cap

₹ 15779.1 crore

Last updated on: Feb 21, 2025

Key Highlights

  • The Market Cap of Alembic Pharmaceuticals Ltd is ₹ 15779 crore as of 21 Feb 25 .
  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 802.75 as of 21 Feb 15:30 .
  • The dividend payouts of Alembic Pharmaceuticals Ltd changed from ₹ 7 to ₹ 11 over 6 quarters. This represents a CAGR of 35.16% .
Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Share Price

₹ 802.75

-10.55 (-1.30%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025802.75
20 Feb 2025813.3
19 Feb 2025812.45
18 Feb 2025810.45
17 Feb 2025814
14 Feb 2025818.1
13 Feb 2025826.2
12 Feb 2025845.2
11 Feb 2025868.95
10 Feb 2025885.45

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alembic Pharmaceuticals Ltd

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Alembic Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Alembic Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Alembic Pharmaceuticals Ltd

No data available

* All values are in

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f

Read more

13 Aug 24

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa

Read more

13 Aug 24

Alembic Pharmaceuticals Ltd leads losers in 'A' group

Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t

Read more

09 Aug 24

Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J

Read more

08 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Alembic Pharmaceuticals Ltd Market Cap

What is the market cap of Alembic Pharmaceuticals Ltd?

As of February 22, 2025, Alembic Pharmaceuticals Ltd has a market capitalization of ₹15779.1, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Alembic Pharmaceuticals Ltd's market capitalization?

Alembic Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Alembic Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Alembic Pharmaceuticals Ltd's market capitalization change?

Alembic Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions